No image available
by Georg W. Herget, Babak Ebrahimzadeh Saravi, Eugenia Schwarzkopf, Mara Milena Wigand, Norbert P. Südkamp, Hagen Schmal, Markus Uhl, Gernot Michael Lang · 2021
ISBN: Unavailable
Category: Unavailable
Page count: Unavailable
Abstract: Background<br>Skeletal-related events (SREs) due to bone metastases (BM) significantly impact the morbidity and mortality of cancer patients. The present study sought to investigate clinicopathological characteristics, metastasis-free survival (MFS), and SREs in patients referred to a tertiary orthopedic and trauma center.<br><br>Methods<br>Data were retrieved from electronic health records (n=628). Survival curves were estimated utilizing the Kaplan-Meier method. The Cox regression model was used to determine factors influencing MFS based on estimated hazard ratios (HRs).<br><br>Results<br>Breast (55.8%) and lung (18.2%), and lung (32.9%) and prostate (16.8%) cancer were the most common cancer types in our cohort in women and men, respectively. Fifteen percent of patients presented with BM as the first manifestation of tumor disease, 23% had metastasis diagnosis on the same day of primary tumor diagnosis or within 3 months, and 62% developed BM at least 3 months after primary tumor diagnosis. Osteolytic BM were predominant (72.3%) and most commonly affecting the spine (23%). Overall median MFS was 45 months (32 (men) vs. 53 (women) months). MFS was shortest in the lung (median 15 months, 95% CI 8.05-19) and longest in breast cancer (median 82 months, 95% CI 65.29-94). Age (≥ 60 vs. 60 years) and primary cancer grading of ≥2 vs. 1 revealed prognostic relevance.brbrConclusion